Research.Patient.info
Advanced Renal Cell Carcinoma research hub
2 indexed studies · 0 currently recruiting
- active not recruiting
Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.
This study looks at how a treatment called cabozantinib, used alone or with another drug called nivolumab, works for people in the UK with advanced kidney cancer. Researchers want to see how patients use these drugs in normal clinic visits and understand any side effects.
Austria · Germany - active not recruitingPHASE1
A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma
This study looks at new drug combinations for advanced kidney cancer. We want to see how safe and effective MEDI5752 is when given with either Lenvatinib or Axitinib to people with this type of cancer.
United States · Australia · France